Your browser doesn't support javascript.
loading
Tumour-selective antivascular effects of the novel anti-mitotic compound A-318315: An in vivo rat regional haemodynamic study.
Segreti, Jason A; Brooks, Kristin A; Marsh, Kennan C; Bauch, Joy L; Lan, Yan; Thomas Lin, C; Rosenberg, Saul H; Sham, Hing L; Reinhart, Glenn A; Cox, Bryan F; Polakowski, James S.
Affiliation
  • Segreti JA; Abbott Laboratories, Global Pharmaceutical Research and Development, Abbott Park, IL, USA. Jason.Segreti@abbott.com
Clin Exp Pharmacol Physiol ; 37(5-6): 636-40, 2010 May.
Article in En | MEDLINE | ID: mdl-20132238
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Sulfonamides / Angiogenesis Inhibitors / Antimitotic Agents / Hemodynamics / Indoles / Neovascularization, Pathologic Type of study: Prognostic_studies Limits: Animals Language: En Journal: Clin Exp Pharmacol Physiol Year: 2010 Type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Sulfonamides / Angiogenesis Inhibitors / Antimitotic Agents / Hemodynamics / Indoles / Neovascularization, Pathologic Type of study: Prognostic_studies Limits: Animals Language: En Journal: Clin Exp Pharmacol Physiol Year: 2010 Type: Article Affiliation country: United States